{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:03:46Z","timestamp":1791216226091,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1124\/mol.110.067447","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T23:14:53Z","timestamp":1297379693000},"page":"833-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-\u03b21 Signaling in Endothelial Cells"],"prefix":"10.1016","volume":"79","author":[{"given":"Virginia","family":"Albi\u00f1ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Sanz-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Recio-Poveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Bernab\u00e9u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M.","family":"Botella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.110.067447_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jmg.2005.030833","article-title":"Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease","volume":"43","author":"Abdalla","year":"2006","journal-title":"J Med Genet"},{"key":"10.1124\/mol.110.067447_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1160\/TH09-07-0425","article-title":"Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells","volume":"103","author":"Albi\u00f1ana","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1124\/mol.110.067447_bib3","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/ajmg.a.31450","article-title":"A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7","volume":"140","author":"Bayrak-Toydemir","year":"2006","journal-title":"Am J Med Genet"},{"key":"10.1124\/mol.110.067447_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2478\/v10136-009-0020-x","article-title":"Involvement of the TGF-beta superfamily signalling pathway in hereditary haemorragic telangiectasia","volume":"8","author":"Bernabeu","year":"2010","journal-title":"J Appl Biomed"},{"key":"10.1124\/mol.110.067447_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcp.20311","article-title":"Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex","volume":"204","author":"Blanco","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.110.067447_bib6","doi-asserted-by":"crossref","first-page":"34486","DOI":"10.1074\/jbc.M011611200","article-title":"Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation","volume":"276","author":"Botella","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067447_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jmg.2004.028712","article-title":"A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5","volume":"42","author":"Cole","year":"2005","journal-title":"J Med Genet"},{"key":"10.1124\/mol.110.067447_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1160\/TH06-07-0373","article-title":"Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1\/endoglin pathway in endothelial cells","volume":"97","author":"Fernandez-L","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1124\/mol.110.067447_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cardiores.2005.06.009","article-title":"Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions","volume":"68","author":"Fernandez-L","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1124\/mol.110.067447_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.9413","article-title":"Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1","volume":"27","author":"Fernandez","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1124\/mol.110.067447_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2350-9-75","article-title":"Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia","volume":"9","author":"Fontalba","year":"2008","journal-title":"BMC Med Genet"},{"key":"10.1124\/mol.110.067447_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2199-11-51","article-title":"Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1","volume":"11","author":"Garrido-Martin","year":"2010","journal-title":"BMC Mol Biol"},{"key":"10.1124\/mol.110.067447_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1160\/TH08-01-0044","article-title":"Hereditary haemorrhagic telangiectasia (HHT): negotiating between the Scylla of bleeding and Charybdis of thrombosis","volume":"100","author":"Ghosh","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1124\/mol.110.067447_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cvr\/cvn079","article-title":"FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation","volume":"79","author":"Giordano","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1124\/mol.110.067447_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0303-8467(93)90123-X","article-title":"Cerebral arteriovenous malformations in The Netherlands Antilles. High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations","volume":"95","author":"Jessurun","year":"1993","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1124\/mol.110.067447_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","article-title":"Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2","volume":"13","author":"Johnson","year":"1996","journal-title":"Nat Genet"},{"key":"10.1124\/mol.110.067447_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot"},{"key":"10.1124\/mol.110.067447_bib18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot"},{"key":"10.1124\/mol.110.067447_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","article-title":"Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients","volume":"245","author":"Kjeldsen","year":"1999","journal-title":"J Intern Med"},{"key":"10.1124\/mol.110.067447_bib20","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","article-title":"Endoglin promotes endothelial cell proliferation and TGF-beta\/ALK1 signal transduction","volume":"23","author":"Lebrin","year":"2004","journal-title":"EMBO J"},{"key":"10.1124\/mol.110.067447_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/geno.1995.1147","article-title":"A locus for cerebral cavernous malformations maps to chromosome 7q in two families","volume":"28","author":"Marchuk","year":"1995","journal-title":"Genomics"},{"key":"10.1124\/mol.110.067447_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat Genet"},{"key":"10.1124\/mol.110.067447_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/mol.108.053140","article-title":"Targeting protein serine\/threonine phosphatases for drug development","volume":"75","author":"McConnell","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067447_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0001-6519(07)74897-5","article-title":"[Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid]","volume":"58","author":"Morales-Angulo","year":"2007","journal-title":"Acta Otorrinolaringol Esp"},{"key":"10.1124\/mol.110.067447_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0194-5998(98)70065-8","article-title":"A Hereditary hemorrhagic telangiectasia","volume":"119","author":"Morales-Angulo","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1124\/mol.110.067447_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajmg.1320320302","article-title":"Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population","volume":"32","author":"Plauchu","year":"1989","journal-title":"Am J Med Genet"},{"key":"10.1124\/mol.110.067447_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.transproceed.2004.12.154","article-title":"Regulators of angiogenesis in renal ischemia\/reperfusion injury in normotensive and hypertensive rats: effect of tacrolimus","volume":"37","author":"Rajnoch","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1124\/mol.110.067447_bib28","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V92.12.4677","article-title":"Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1","volume":"92","author":"R\u00edus","year":"1998","journal-title":"Blood"},{"key":"10.1124\/mol.110.067447_bib29","doi-asserted-by":"crossref","first-page":"43799","DOI":"10.1074\/jbc.M207160200","article-title":"Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways","volume":"277","author":"S\u00e1nchez-Elsner","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067447_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"key":"10.1124\/mol.110.067447_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/thx.54.8.714","article-title":"Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms","volume":"54","author":"Shovlin","year":"1999","journal-title":"Thorax"},{"key":"10.1124\/mol.110.067447_bib32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH07-01-0064","article-title":"Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism","volume":"98","author":"Shovlin","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1124\/mol.110.067447_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/0003-4819-144-3-200602070-00030","article-title":"Regression of cutaneous and gastrointestinal telangiectasia with sirolimus and aspirin in a patient with hereditary hemorrhagic telangiectasia","volume":"144","author":"Skaro","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1124\/mol.110.067447_bib34","first-page":"200","article-title":"[Immunophilins: neuroprotective agents and promoters of neural regeneration]","volume":"17","author":"Udina","year":"2002","journal-title":"Neurologia"},{"key":"10.1124\/mol.110.067447_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0037-1615709","article-title":"Hemostatic effects of tamoxifen in hereditary hemorrhagic telangiectasia","volume":"85","author":"Zacharski","year":"2001","journal-title":"Thromb Haemost"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24029584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24029584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.110.067447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:51:36Z","timestamp":1739940696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24029584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0026895X24029584"],"URL":"https:\/\/doi.org\/10.1124\/mol.110.067447","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor-\u03b21 Signaling in Endothelial Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.110.067447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}